Declaration of competing financial interests
From the following article
Engineering Escherichia coli for production of functionalized terpenoids using plant P450s
Michelle C Y Chang, Rachel A Eachus, William Trieu, Dae-Kyun Ro & Jay D Keasling
Nature Chemical Biology 3, 274 - 277 (2007) Published online: 15 April 2007
doi:10.1038/nchembio875
Declaration: J.D.K. owns shares of Amyris Biotechnologies, a company that is currently using the technology described here to produce the antimalarial drug artemisinin. Neither Amyris nor the University of California will make any profit (or royalties) from the sale of artemisinin in the developing world.
